2023
DOI: 10.3390/biomedicines11092394
|View full text |Cite
|
Sign up to set email alerts
|

Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease

Suzanne M. de la Monte,
Ming Tong,
Andrew J. Hapel

Abstract: Neuroinflammation may be a pathogenic mediator and biomarker of neurodegeneration at the boundary between mild cognitive impairment (MCI) and early-stage Alzheimer’s disease (AD). Whether neuroinflammatory processes are endogenous to the central nervous system (CNS) or originate from systemic (peripheral blood) sources could impact strategies for therapeutic intervention. To address this issue, we measured cytokine and chemokine immunoreactivities in simultaneously obtained lumbar puncture cerebrospinal fluid … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 156 publications
0
0
0
Order By: Relevance
“…These biomarkers include TNFα, IL-1β, IL-4, IL-5, IL-9, IL-13, YKL-40 (also known as chitinase-3-like protein-1 (CHI3L1)), and glial fibrillary acidic protein (GFAP). Additionally, two chemokines, MCP-1, and eotaxin-1, have previously been associated with more significant memory impairment in individuals with Mild Cognitive Impairment (MCI) and AD [8,13,14].…”
Section: Discussionmentioning
confidence: 99%
“…These biomarkers include TNFα, IL-1β, IL-4, IL-5, IL-9, IL-13, YKL-40 (also known as chitinase-3-like protein-1 (CHI3L1)), and glial fibrillary acidic protein (GFAP). Additionally, two chemokines, MCP-1, and eotaxin-1, have previously been associated with more significant memory impairment in individuals with Mild Cognitive Impairment (MCI) and AD [8,13,14].…”
Section: Discussionmentioning
confidence: 99%